Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)

Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location

(2013) Talia Golan et al.   CANCER

Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication

(2013) Paul Lochhead et al.   JNCI-Journal of the National Cancer Institute

Molecular Dissection of Microsatellite Instable Colorectal Cancer

(2013) Eduardo Vilar et al.   Cancer Discovery

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

(2012) H. J. Schmoll et al.   ANNALS OF ONCOLOGY

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

(2012) P. G. Gavin et al.   CLINICAL CANCER RESEARCH

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

(2011) Ben Tran et al.   CANCER

Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer

(2011) Jeong Eun Kim et al.   CANCER SCIENCE

Microsatellite Instability, Prognosis and Drug Sensitivity of Stage II and III Colorectal Cancer: More Complexity to the Puzzle

(2011) S. Tejpar et al.   JNCI-Journal of the National Cancer Institute

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

(2011) F. A. Sinicrope et al.   JNCI-Journal of the National Cancer Institute

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

(2010) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer

(2009) M Koopman et al.   BRITISH JOURNAL OF CANCER

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803

(2009) Monica M. Bertagnolli et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

(2009) Scott Kopetz et al.   JOURNAL OF CLINICAL ONCOLOGY

The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer

(2009) Seung Tae Kim et al.   MEDICAL ONCOLOGY

Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group

(2008) C. I. Müller et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE